IL202760A0 - METHOD FOR SCREENING FORSELECTIVE MODULATOR OF THE NF-kB PATHWAY ACTIVATION - Google Patents
METHOD FOR SCREENING FORSELECTIVE MODULATOR OF THE NF-kB PATHWAY ACTIVATIONInfo
- Publication number
- IL202760A0 IL202760A0 IL202760A IL20276009A IL202760A0 IL 202760 A0 IL202760 A0 IL 202760A0 IL 202760 A IL202760 A IL 202760A IL 20276009 A IL20276009 A IL 20276009A IL 202760 A0 IL202760 A0 IL 202760A0
- Authority
- IL
- Israel
- Prior art keywords
- forselective
- modulator
- screening
- pathway activation
- pathway
- Prior art date
Links
- 102000003945 NF-kappa B Human genes 0.000 title 1
- 108010057466 NF-kappa B Proteins 0.000 title 1
- 230000004913 activation Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 230000037361 pathway Effects 0.000 title 1
- 238000012216 screening Methods 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07290782A EP2006686A1 (en) | 2007-06-22 | 2007-06-22 | Method for screening for selective modulator of the NF-kB pathway activation |
| PCT/IB2008/002633 WO2009001222A2 (en) | 2007-06-22 | 2008-06-20 | METHOD FOR SCREENING FOR SELECTIVE MODULATOR OF THE NF-ϰB PATHWAY ACTIVATION |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL202760A0 true IL202760A0 (en) | 2010-06-30 |
Family
ID=38577422
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL202760A IL202760A0 (en) | 2007-06-22 | 2009-12-15 | METHOD FOR SCREENING FORSELECTIVE MODULATOR OF THE NF-kB PATHWAY ACTIVATION |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20100240040A1 (ja) |
| EP (2) | EP2006686A1 (ja) |
| JP (1) | JP2010530970A (ja) |
| CN (1) | CN101802619A (ja) |
| AU (1) | AU2008269444A1 (ja) |
| BR (1) | BRPI0814721A2 (ja) |
| CA (1) | CA2692112A1 (ja) |
| IL (1) | IL202760A0 (ja) |
| WO (1) | WO2009001222A2 (ja) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112015013710B1 (pt) * | 2012-12-12 | 2022-08-09 | Promega Corporation | Métodos in vitro para detectar uma interação entre um agente bioativo e um alvo celular |
| CN107271687A (zh) * | 2017-07-14 | 2017-10-20 | 郑州大学 | 利用HTRF技术筛选UBC12/Dcn1小分子抑制剂的方法 |
| WO2020082016A1 (en) * | 2018-10-18 | 2020-04-23 | The General Hospital Corporation | Targeting the non-canonical nfkb pathway in cancer immunotherapy |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040053324A1 (en) * | 2002-08-30 | 2004-03-18 | Brian Wong | Assays and compositions for identifying agents that modulate the activity of deubiquitinating agents |
| CA2540103C (en) * | 2003-09-24 | 2017-11-07 | Institut Pasteur | Selective inhibition of nf-kappab activation by peptides designed to disrupt nemo oligomerization |
-
2007
- 2007-06-22 EP EP07290782A patent/EP2006686A1/en not_active Ceased
-
2008
- 2008-06-20 EP EP08807211A patent/EP2174141A2/en not_active Withdrawn
- 2008-06-20 CN CN200880104245A patent/CN101802619A/zh active Pending
- 2008-06-20 WO PCT/IB2008/002633 patent/WO2009001222A2/en active Application Filing
- 2008-06-20 BR BRPI0814721-3A2A patent/BRPI0814721A2/pt not_active IP Right Cessation
- 2008-06-20 CA CA002692112A patent/CA2692112A1/en not_active Abandoned
- 2008-06-20 US US12/666,128 patent/US20100240040A1/en not_active Abandoned
- 2008-06-20 AU AU2008269444A patent/AU2008269444A1/en not_active Abandoned
- 2008-06-20 JP JP2010512810A patent/JP2010530970A/ja active Pending
-
2009
- 2009-12-15 IL IL202760A patent/IL202760A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2008269444A1 (en) | 2008-12-31 |
| WO2009001222A3 (en) | 2009-05-22 |
| JP2010530970A (ja) | 2010-09-16 |
| EP2006686A1 (en) | 2008-12-24 |
| CA2692112A1 (en) | 2008-12-31 |
| WO2009001222A2 (en) | 2008-12-31 |
| BRPI0814721A2 (pt) | 2015-02-24 |
| EP2174141A2 (en) | 2010-04-14 |
| US20100240040A1 (en) | 2010-09-23 |
| CN101802619A (zh) | 2010-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1212650A1 (zh) | 篩分方法和篩分設備 | |
| GB2468006C (en) | Screening | |
| GB2469585B (en) | Urinal apparatus | |
| PL2194783T3 (pl) | Kompozycje i sposoby dla modulatorów apoptozy | |
| EP2132570A4 (en) | SCREENING METHOD | |
| GB0701992D0 (en) | Grehlin Receptor Modulators | |
| GB0702402D0 (en) | Method of creating crystalline substances | |
| EP2087129A4 (en) | METHOD FOR IDENTIFYING MODULATORS OF THE NRF2-KEAP1-ARE PATH | |
| GB0710976D0 (en) | Am Screening method | |
| IL202760A0 (en) | METHOD FOR SCREENING FORSELECTIVE MODULATOR OF THE NF-kB PATHWAY ACTIVATION | |
| GB2467669B (en) | Improved urinal apparatus | |
| GB0725125D0 (en) | urinal apparatus | |
| GB0602176D0 (en) | Screening method | |
| GB0620577D0 (en) | Brake assemblies | |
| EP2243830A4 (en) | SCREENING PROCESS | |
| ZA200806237B (en) | Cannibinoid receptor modulators | |
| EP1997902A4 (en) | SCREENING PROCESS | |
| EP2173695A4 (en) | PROCESS FOR THE PREPARATION OF CIS-4-TERT.-BUTYLCYCLOHEXANOL | |
| GB0610542D0 (en) | Screening method | |
| PL1996763T3 (pl) | Urządzenie przesiewające | |
| AU2007905522A0 (en) | Method of screening for anticancer agents | |
| GB0710510D0 (en) | Screening method | |
| AU2007905334A0 (en) | Screening method | |
| AU2007901452A0 (en) | Method of screening | |
| AU2007904304A0 (en) | Method of screening |